Retinopathy of Prematurity. Part I
Authors:
Z. Prepiaková; D. Tomãíková; B. Kostolná; A. Gerinec
Authors‘ workplace:
Klinika detskej oftalmológie DFNsP- LFUK, Bratislava, prednosta kliniky
prof. MUDr. Anton Gerinec, CSc.
Published in:
Čes. a slov. Oftal., 70, 2014, No. 2, p. 44-49
Category:
Comprehensive Report
Overview
Retinopathy of prematurity (ROP) is a disease that affects immature vasculature in the eyes of premature babies that potentially leads to blindness. Authors describe incidence, risk factors, pathophysiology and international classification of retinopathy of prematurity (ICROP).
Key words:
retinopathy of prematurity, incidence, pathophysiology, international classification
Sources
1. Avery, M.E.: Recent increase in mortality from hyaline membrane disease. J Pediatr, 57, 1960: 553–559.
2. Blencowe, H., Lee, A. C., Cousens, S., et al.: Preterm birth-associated neurodevelopmental impairment estimates at regional and global levels for 2010. Pediatric research, 74(S1); 2013: 17–34.
3. Cryotherapy for Retinopathy of Prematurity Cooperative Group: The natural ocular outcome of premature birth and retinopathy. Arch Ophthalmol, 112; 1994: 903–912.
4. Early Treatment for Retinopathy of Prematurity Cooperative Group: Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol, 121(12); 2003: 1684–1694.
5. Fielder, A. R., Reynolds, J. D.: Retinopathy of prematurity: clinical aspects. Seminars in Neonatology, WB Saunders, 6(6; 2001: 461–475.
6. Flynn, J.T., Chan-Ling, T.: Retinopathy of prematurity: two distinct mechanisms that underlie zone 1 and zone 2 disease. Am J Ophthalmol, 142(1); 2006: 46–59.
7. Gergely, K., Gerinec, A.: Retinopathy of prematurity-epidemics, incidence, prevalence, blindness. Bratisl Lek Listy, 111(9); 2010: 514–517.
8. Gerinec, A.: Choroby sietnice. In Gerinec, A ( Osveta), Detská oftalmológia, Kniha, Martin, Osveta, 2005, s. 431–445.
9. Gilbert, C.G. et al.: Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatric, 115(5); 2005: 518–525.
10. Hughes, S., Yan, H., Chan-Ling, T.: Vascularisation of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci, 41; 2000: 1217–1228.
11. Chovancová, D.: Starostlivosť o hranične nezrelého novorodenca z aspektu všeobecného lekára pre deti a dorast. Pediatr. prax, 11(1); 2010: 6–10.
12. International Committee for the Classification of Retinopathy of Prematurity: The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol, 123(7); 2005: 991–9.
13. LIGHT-ROP Cooperative Group: The design of the multicenter study of light reduction in retinopathy of prematurity (LIGHT-ROP). J Pediatr Ophthalmol Strabismus, 36; 1999: 257– 263.
14. McDonald, A. D.: Cerebral palsy in children of very low birth weight. Arch Dis Child., 38(202), 1963: 579–588.
15. Moore, T., Hennessy, E. M., Myles, J., et al.: Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ: Brit Med J, 2012: 345.
16. Provis, J.M., Leech, J., Diaz, C.M. et al.: Development of the human retinal vasculature: cellular relations and VEGF165 expression.65, Exper Eye Res, 1997: 555–568.
17. Ramanathan, R., Siassi, B., deLemos, R.A.: Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy. J Perinatol., 15(3); 1995: 178-82; quiz 183–184.
18. Repka, M.X., Palmer, E.A., Tung, B.: On behalf of the CRYO-ROP Cooperative Group, Involution of retinopathy of prematurity. Arch Ophthalmol, 118; 2000: 645–649.
19. Rundle, P., McGinnity, F.G.: Bilateral hyphaema following diode laser for retinopathy of prematurity. British Journal of Ophthalmology, 79(11); 1995: 1055–1056.
20. Smith, L. E.: Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture. Invest Ophthalmol Vis Sci, 49(12); 2008: 5177–5182.
21. Stone, J., Itin, A., Alon, T. et al.: Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF165) expression by neuroglia. J Neurosci, 15; 1995: 4739–4747.
22. Terry, T.L.: Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. I. Preliminary report. Am J Ophthalmol, 25; 1942: 203–204.
23. The Committee for the Classification of Retinopathy of Prematurity: An international classification of retinopathy of prematurity Arch Ophthalmol, 102; 1984: 1130–1134.
24. The Committee for the Classification of the Late Stages of Retinopathy of Prematurity: An international classification of retinopathy of prematurity. Arch Ophthalmol, 105; 1987: 906–912.
25. The STOP-ROP Multicenter Study Group: Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP): a randomized, controlled trial I: primary outcomes. Pediatrics, 105; 2000: 295–310.
Labels
OphthalmologyArticle was published in
Czech and Slovak Ophthalmology
2014 Issue 2
Most read in this issue
- Extraocular Muscle Involvement in Patients with Thyroid-associated Orbitopathy
- Retinopathy of Prematurity. Part I
- Acute Posterior Multifocal Placoid Pigment Epitheliopathy – Case Report
- Retinopathy of Prematurity – Therapy. Part 2